Influenza Nucleoprotein antibody (Influenza A Virus (A/WSN/1933))
Quick Overview for Influenza Nucleoprotein antibody (Influenza A Virus (A/WSN/1933)) (ABIN7468473)
Target
See all Influenza Nucleoprotein (NP) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Virus Strain
- A/WSN/1933
-
Cross-Reactivity
- Influenza A Virus
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein of Influenza A virus Nucleoprotein (A/WSN/1933(H1N1). The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:5000-1:20000. ICC/IF: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: DF1 (Influenza A virus treatment for 10hr) Validation: Orthogonal
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.43 mg/mL
-
Buffer
- 1XPBS pH 7, 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Influenza Nucleoprotein (NP)
-
Alternative Name
- Influenza A virus Nucleoprotein
-
Target Type
- Influenza Protein
-
Background
- Influenza A Virus Nucleoprotein , Influenza A Virus NP
Target
-